Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

QGEN MYGN ACTG FORR EUR Bitcoins Heavy Metals Small Blend IT 
Benchmark SP 500  1,652   12.77  Index Moved Up 0.78% United States ...


Processing
Collecting data for MYGN

Myriad quote and profile

 
 Companies |  Insiders  | Dashboard  
     
26.44
  
STOCK
(0.18)  Macroaxis: -0.68 Down   0.68%  
Year To Date
22.0238.27
Last 1 Month(s)
26.6234.26
Trading Day 
25.9726.89
June 18 2013 

Diversification Suggestion

Use Myriad to protect against small markets fluctuations. The stock experiences moderate downward daily trend and can be a good diversifier
Analyze Myriad Genetics Trend or Check current 30 days Myriad correlation with market (S&P 500)
1 Month Beta 1.1  
Highest Price:  
Lowest Price:  
34.26  
26.62  
June 11 2013 
June 17 2013 
Myriad returns are very sensitive to returns on the market. As market goes up or down, Myriad is expected to follow.
Myriad Genetics Inc llmost one BetaMyriad Genetics Beta Legend
MYGN United States Nasdaq
Myriad Genetics Inc
Services
Research Services
Benchmark S&P 500
http://www.myriad.com
Contact Number: 801. 584. 3600
Currency: USD - US Dollar
Traded on NASDAQ
    
Current Valuation2.37 B
Shares Outstanding79.65 M
Number of Shares Shorted4.38 M
Revenue572.02 M
 United States Russel   1.23 % Macroaxis: change 1.23 Moved Up  
 
 United States SP 500   0.78 % Macroaxis: 0.78 Moved Up  
 
 United States NYSE   0.66 % Macroaxis: 0.66 Moved Up  
 
 thisRed MYGN MYGN agains markets  0.68 % Macroaxis: 0.68 Moved Down  
 
Compare to Competition Alpha & Beta   Get Advice

Myriad Leadership

Peter Meldrum CEO and President and Director, MBA
John Henderson Independent Chairman of the Board
Walter Gilbert Founding Scientist, Vice Chairman and Member of Compensation Committee
Gary King Executive Vice President - International Operations, MBA

Myriad Price and Market Media

The median price of Myriad for the period between Sun, May 19, 2013 and Tue, Jun 18, 2013 is 32.17 with a coefficient of variation of 5.93. The daily time series for the period is distributed with a sample standard deviation of 1.89, arithmetic mean of 31.81, and mean deviation of 1.24. The Stock received substential amount of media coverage during this period.
Myriad         SP 500
Price Growth (%)
 
Change Benchmark  Embed  Export  Timeline
1
Myriad Genetics Inc. Product Pipeline Analysis 2013 Update N...05/29/2013Macroaxis: News
2
Hedge Funds Are Selling Myriad Genetics Inc.05/31/2013Macroaxis: News
3
MYRIAD GENETICS INC. Myriad Genetics to Present at the Goldm...06/04/2013Macroaxis: News
4
Judgment Day for Myriad Genetics Inc.06/06/2013Macroaxis: News
5
Myriad Genetics To Present At Goldman Sachs Conference Webca...06/12/2013Macroaxis: News

Myriad Summary

Myriad Genetics Inc [MYGN] is traded on NASDAQ in USA. It is located in Salt Lake City, UT and employs 1,169 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 2.2 B. Myriad Genetics Inc conducts business under Services sector and is part of Research Services industry. This company has 79.65 M outstanding shares of which 4.38 M shares are now shorted by private and institutional investors with about 4.9 trading days to cover.
Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive medicine, personalized medicine, and prognostic medicine tests primarily in the United States. more
Past Market
Over 30
Days
0
Out Of
100
 
Chance of
Less
Than
13 %
 
Follow Myriad with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Myriad to your reader
 

Myriad Research Report

Myriad vs. Qiagen

Correlation analysis and fundamentals comparison between Myriad Genetics and Qiagen NV

Myriad Executives

James Evans CFO, Principal Accounting Officer and Treasurer

Myriad Directors

Lawrence Best Independent Director
S Phanstiel Independent Director
Heiner Dreismann Independent Director
Dennis Langer Independent Director, Ph.D

Myriad Management

Richard Esq Executive VP, General Counsel and Secretary

Myriad Fundamentals

Earnings Per Share vs Return On Equity
Book Value Per Share vs Retained Earnings
Earnings Per Share vs Number of Employees
Price to Earning vs Retained Earnings

Myriad vs Competition

Myriad vs. Qiagen NV
Myriad vs. National Research Corp

Myriad June 18 2013 Opportunity Range

Downside Deviation4.67
Information Ratio(0.23)
Maximum Drawdown19.8
Value At Risk(5.63)
Potential Upside3.37

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium